Retractable Technologies (Retractable Technologies) Gross Profit : $9.11 Mil (TTM As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Retractable Technologies Gross Profit?

Retractable Technologies's gross profit for the three months ended in Dec. 2023 was $1.54 Mil. Retractable Technologies's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was $9.11 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Retractable Technologies's gross profit for the three months ended in Dec. 2023 was $1.54 Mil. Retractable Technologies's Revenue for the three months ended in Dec. 2023 was $14.29 Mil. Therefore, Retractable Technologies's Gross Margin % for the quarter that ended in Dec. 2023 was 10.78%.

Retractable Technologies had a gross margin of 10.78% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage

During the past 13 years, the highest Gross Margin % of Retractable Technologies was 50.62%. The lowest was 20.89%. And the median was 34.25%.

Warning Sign:

Retractable Technologies Inc gross margin has been in long-term decline. The average rate of decline per year is -6.1%.

Retractable Technologies Gross Profit Historical Data

The historical data trend for Retractable Technologies's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Retractable Technologies Gross Profit Chart

Retractable Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross Profit

Get a 7-Day Free Trial

14.14

37.01

95.35

28.25

9.11

Retractable Technologies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross Profit	Get a 7-Day Free Trial															4.30	2.87	0.38	4.32	1.54

Competitive Comparison of Retractable Technologies's Gross Profit

For the Medical Instruments & Supplies subindustry, Retractable Technologies's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Retractable Technologies's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Retractable Technologies's Gross Profit distribution charts can be found below:

* The bar in red indicates where Retractable Technologies's Gross Profit falls into.

Retractable Technologies Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Retractable Technologies's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )	=	Revenue	-	Cost of Goods Sold
	=	43.597	-	34.489
	=	9.11

Retractable Technologies's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )	=	Revenue	-	Cost of Goods Sold
	=	14.29	-	12.749
	=	1.54

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.11 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Retractable Technologies's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )	=	Gross Profit (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	1.54	/	14.29
	=	10.78 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Retractable Technologies (AMEX:RVP) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Retractable Technologies had a gross margin of 10.78% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage

Retractable Technologies Gross Profit Related Terms

Thank you for viewing the detailed overview of Retractable Technologies's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

Retractable Technologies (Retractable Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Retractable Technologies Inc (AMEX:RVP) » Definitions » Gross Profit

Comparable Companies

Traded in Other Exchanges

N/A

Address

511 Lobo Lane, Little Elm, TX, USA, 75068-5295

Website

https://www.retractable.com

Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to its other products.

Executives

Thomas J Shaw	director, 10 percent owner, officer: President and CEO	511 LOBO LANE, LITTLE ELM TX 75068
Braden Michael Leonard	10 percent owner	156 S. FIRST STREET, ZIONSVILLE IN 46077
Bigby Walter O Jr	director	816 BENTON RD, BOSSIER CITY LA 71111
Darren E Findley	director	1618 GRASSMERE RD, FRANKLIN TN 37064
Russell B Kuhlman	director, officer: Vice President of Sales	511 LOBO LANE, PO BOX 9, LITTLE ELM TX 75068
Fort John W Iii	director, officer: Chief Financial Officer	511 LOBO LANE, LITTLE ELM TX 75068
Amy Mack	director	1701 LEGACY DRIVE SUITE 100, FRISCO TX 75034
Clarence D Zierhut	director	1217 BLUEBIRD LANE, GARLAND TX 75042
Lillian E Salerno	10 percent owner	777 7TH AVENUE, UNIT 308, WASHINGTON DC 20001
Suzanne M August	10 percent owner	340 NORTH JULIA CIRCLE, ST. PETERSBURG FL 33706
Steven R Wisner	director, officer: Exec. VP, Eng & Prod.	511 LOBO LANE, PO BOX 9, LITTLE ELM TX 75068
Marco Laterza	director	P.O. BOX 64104, EL PASO TX 79904
Jimmie Shiu	director	511 LOBO LANE, P.O. BOX 9, LITTLE ELM TX 75068
Patti King	director	9145 MARTIN ROAD, ROSWELL GA 30076
Michele Larios	officer: Vice President/General Counsel	511 LOBO LANE, LITTLE ELM TX 75068

Retractable Technologies (Retractable Technologies) Headlines

From GuruFocus

Retractable Technologies Inc (RVP) CEO Thomas J Shaw buys 200,000 Shares

By gurufocus • 03-16-2009

Is Retractable Technologies (RVP) Modestly Undervalued? A Comprehensive Analysis

By GuruFocus Research • 08-22-2023